(Finance) – Theshareholders meeting Of doValuea company listed on Euronext Milan and active in the management and recovery of non-performing loans, has approved the proposals presented by the board of directors as part of the key steps for the implementation of theAcquisition of Gardant.
In particular, it resolved to approve the proposal of the Board of Directors of increase the share capital for a maximum total amount of 150 million euros, through the issue of ordinary shares with no nominal value, with the same characteristics as those in circulation, to be offered as an option to shareholders.
also approved theissuance of a Convertible Bond in ordinary shares up to 20% of the share capital of doValue with a consequent increase in share capital with the exclusion of the option right pursuant to art. 2441, paragraph 5, of the Civil Code, to be offered to Gardant shareholders as part of the acquisition
Subject to the release of the necessary Permissions by the competent Authorities, the option offer will be launched immediately after the completion of the acquisition of Gardant.
The rights offering is subscribed by a group of reference shareholders for an amount of approximately 82.5 million euros. A pool of Italian banks, market leaders, will act as Joint Global Coordinators and Joint Bookrunners in relation to the rights offering and has entered into a pre-underwriting agreement for the residual market risk of approximately 62.5 million euros.
It was also decided that Grouping of shares ordinary shares of doValue in the ratio of 1 new ordinary share with regular entitlement for every 5 existing ordinary shares.